NexusPharma is dedicated to the discovery of novel therapeutics that modulate protein-protein interactions. Novel drug candidates will be advanced into clinical development for the treatment of cancer through approaches based on non-cytotoxic mechanisms. Thus, NexusPharma also develops new technologies that aid drug discovery – such as novel cell based screening assays or patient derived tumor models. Please ask us if we could help you in your discovery projects with these technologies !
info@nexuspharm.com